UFP Technologies, Inc. reported a significant increase in financial performance for the fiscal year ending December 31, 2025, with net sales rising 19.5% to $602.8 million, compared to $504.4 million in 2024. This growth was primarily driven by a 23.2% increase in sales to the medical market, bolstered by contributions from recent acquisitions, which added approximately $168.3 million in sales during the year. However, the company's gross profit margin decreased slightly to 28.3% from 29.1% in the previous year, attributed to rising overhead and labor costs, despite a reduction in material costs.
Selling, General, and Administrative Expenses (SG&A) also saw a notable increase of 24.5%, totaling $77.4 million in 2025, up from $62.2 million in 2024. This rise was largely due to increased headcount and back-office resources, with SG&A from acquisitions contributing approximately $17.8 million. As a percentage of sales, SG&A increased to 12.8% from 12.3% in the prior year. The company incurred $0.3 million in acquisition-related costs, a decrease from $2.5 million in 2024, reflecting a more streamlined approach to integrating new businesses.
UFP Technologies continued its strategic expansion through several acquisitions, including AJR Specialty, AJR Custom Foam, Techno Plastics Industries, and Universal Plastics & Engineering, which collectively contributed to the company's growth. The total assets and net sales from these acquisitions represented approximately 2.4% and 2.0% of the company's consolidated totals, respectively. The company also reported a net cash provided by operations of approximately $91.9 million, driven by net income of $68.3 million and depreciation and amortization of $19.2 million.
The company’s total long-term debt decreased to $135.5 million as of December 31, 2025, down from $189.4 million in 2024, primarily due to repayments on its revolving credit facility and term loan. The weighted average interest rate on outstanding borrowings was approximately 5.1%. UFP Technologies remains committed to enhancing operational efficiencies and may pursue additional acquisitions to support its growth strategy. The company anticipates that its existing resources, along with cash generated from operations, will be sufficient to meet its cash flow requirements over the next twelve months.
Looking ahead, UFP Technologies expressed optimism about its growth trajectory, citing the potential for continued demand in the medical market and the benefits of recent acquisitions. The company is also mindful of external economic factors, including inflation and market volatility, which could impact its future performance. Overall, UFP Technologies aims to leverage its expanded capabilities and market presence to drive further growth in the coming fiscal year.
About UFP TECHNOLOGIES INC
UFP Technologies, Inc. designs and manufactures custom engineered solutions primarily for the medical device, aerospace, defense, automotive, and industrial markets. Its core products include medical device components, sterile packaging, automotive interior parts, and aerospace composites. The company leverages advanced materials, engineering expertise, and proprietary technology to serve top OEMs worldwide, emphasizing innovation, quality, and regulatory compliance in highly specialized, niche segments.
About 10-K Filings
A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.
Key points about the 10-K:
- Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
-
Content: It includes:
- Detailed financial statements audited by an independent accounting firm
- Management's Discussion and Analysis (MD&A) of financial condition and results
- Description of the company's business, properties, and legal proceedings
- Risk factors and market risks
- Executive compensation and corporate governance information
- Importance: Considered the most comprehensive and important document a public company files with the SEC.
- Length: Often exceeds 100 pages due to its extensive and detailed nature.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.